European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

P&G Health Germany GmbH, Schwalbach a. Taunus, Germany

Watch
P&G Health Germany GmbH

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier provides comprehensive company details as a PDF, together with all underlying original publications and original data in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Power Dossier
Entire company details along with all original publications / original data bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €/month

Learn more
Learn more
View plans

Name

P&G Health Germany GmbH
Merck Selbstmedikation GmbH

Identification

Ut
District Court of Königstein HRB 10156
Ut
District Court of Darmstadt HRB 8102
Lei
529900F6SSO180IZZZ78
EUID
DEM1203.HRB10156

Address

Sulzbacher Str. 40, 65824 Schwalbach a. Taunus, Germany
Darmstadt, Germany

Corporate purpose

The research, manufacture, approval and distribution of pharmaceuticals, diagnostics, medical devices, dietary supplements and other consumer health care products, as well as the holding and management of investments of any kind and all related business transactions.

Financial performance

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Marketing & Tech

Merger & Acquisition & Control

Network

Loading network

Legal Structure

Current legal representatives Legal form information · Proxy policies Premium
Premium
7Managing Director
13Authorized signatory (ppa)
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans
CSV export

Quarterly Exports in CSV

Now available in CSV format and optimized for applications in AI and Analytics:
North Data's quarterly exports have become the industry standard for company information.

Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
One known shareholder
Portfolio and Investments
One known active shareholding
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Return on equity
Employee number
Revenue per employee
Taxes
Cash on hand
Receivables
Liabilities
Cost of materials
Wages and salaries
Average salaries per employee
Pension provisions
Trademarks
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans
Financial Statements Interactive sheets with CSV/Excel download Premium
Premium
Balance
from 2005 to 2025
Profit & Loss
from 2005 to 2025
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans

Publications

13 Aug 2026 via Procter & Gamble Germany Holding GmbH also 15/07/2025, 21/10/2024
Shareholder: Procter & Gamble Germany Holding GmbH
29 Jun 2026 via P&G Consumer Health Germany GmbH also 07/08/2024, 10/08/2023, 21/07/2021
Shareholding: P&G Consumer Health Germany GmbH
18 Jun 2026
Annual report for the year ending 30/06/2025 · Balance sheet for 30/06/2025 · Earnings statement for 30/06/2025 · SH: Kooperation Phytopharmaka GbR, P&G Consumer Health Germany GmbH, P&G Health …
16 Mar 2026
Authorized signatory (ppa): Lars Fichtler, Silke Oberst
11 Feb 2026
Authorized signatory (ppa): Simone Müller, Nicola Paulo · No longer Authorized signatory (ppa) (3)
12 Jan 2026
Wordmark: “VIGANTOLETTEN“
17 Dec 2025
No longer Authorized signatory (ppa): Roland Bennewitz
11 Sept 2025
No longer Authorized signatory (ppa): Ralf Gobbers
14 Jul 2025
Annual report for the year ending 30/06/2024 · Balance sheet for 30/06/2024 · Earnings statement for 30/06/2024 · 3 Shareholdings: AM Kapital ApS, P&G Consumer Health Germany GmbH, P G Health Ltd
Year 2025 in Dpmam
10 trademark filings: APESIL, Evion, Femibion, Fluor-Vigantoletten, Neurobion, Tribion, VIGANTOLVIT …
3 Mar 2025
Managing Director: Jochen Tino Brenner, Sandra Dickert · No longer Managing Director: Florian Bender, Matthias Weber · No longer Authorized signatory (ppa): Sandra Dickert
14 Feb 2025
Managing Director: Christoph Reif · No longer Managing Director: Ingo Schimmelpfennig
20 Dec 2024
Share­holder agreement · Corporate Purpose
18 Dec 2024
Original document: “Gesellschaftsvertrag / Satzung / Statut“
8 Oct 2024 via Procter & Gamble Germany GmbH & Co. Operations OHG also 11/08/2021
Shareholder: Procter & Gamble Germany GmbH & Co. Operations OHG
26 Aug 2024
Annual report for the year ending 30/06/2023 · Balance sheet for 30/06/2023 · Earnings statement for 30/06/2023 · 2 Shareholdings: P&G Consumer Health Germany GmbH, P&G Health Austria GmbH & Co. KG OG
16 Aug 2024
Authorized signatory (ppa): Angela Hall · No longer Authorized signatory (ppa) (1)
19 Jul 2024
No longer Authorized signatory (ppa) (1)
9 Jan 2024
Wordmark: “CEBIONELLE“
Year 2023 in Euipotm
8 trademark filings (6 wordmarks, 2 word figurative marks): DIABION, GLUCOBION, LACTOBIOIMMUNO …
17 Oct 2023
Managing Director: Michael Flath · No longer Managing Director: Florian S. Sieben
10 Aug 2023
Profit Transfer: Procter & Gamble Germany Holding GmbH · Control: Procter & Gamble Germany Holding GmbH
3 Aug 2023
Authorized signatory (ppa): Thomas D. Gramminger, Mariia Kolomiitseva · No longer Authorized signatory (ppa): Angela Hall
6 Jul 2023
Managing Director: Barbara Schönfelder · Authorized signatory (ppa): Tobias Bastel, Carina Stolze · No longer Managing Director: Verena Neubauer
6 Jul 2023
Original document: “Liste der Gesellschafter“
19 Jun 2023
Original document: “Liste der Gesellschafter“
12 Apr 2023
Wordmark: “PROBION HARMONIS“
Year 2022 in Euipotm
6 word figurative marks
6 Oct 2022
Word figurative mark: “EVABION“
11 Aug 2022
Authorized signatory (ppa): Frauke Katzenski
4 Aug 2022
Managing Director: Christopher D. Leahy · No longer Managing Director: Rita Maria Walter
14 Jul 2022
Authorized signatory (ppa): Dana Al Rashaideh · No longer Authorized signatory (ppa) (2)
21 Jun 2022
Annual report for the year ending 30/06/2021 · Balance sheet for 30/06/2021 · Earnings statement for 30/06/2021
18 May 2022
Authorized signatory (ppa): Angela Hall · No longer Authorized signatory (ppa) (2)
25 Mar 2022
Figurative mark: “Figurative“
25 Mar 2022
Wordmark: “Ultracarbon“
24 Feb 2022
No longer Authorized signatory (ppa) (1)
18 Jan 2022
Managing Director: Florian Bender · No longer Authorized signatory (ppa): Florian Bender
20 Dec 2021
Managing Director: Verena Neubauer, Astrid Teckentrup · No longer Managing Director: Janis Bauer, Franz-O. Kallerhoff
19 Jul 2021
Authorized signatory (ppa): Angela Brümmer
16 Jul 2021
Annual report for the year ending 30/06/2020 · Balance sheet for 30/06/2020 · Earnings statement for 30/06/2020
1 Jun 2021
Word figurative mark: “dermo mild“
6 Apr 2021
No longer Managing Director: Jens Willi Schewitz
3 Mar 2021
Wordmark: “FLEXIVE“
1 Feb 2021
Managing Director: Rita Maria Walter · No longer Managing Director: Frank Schulze
8 Jan 2021
Word figurative mark: “DERMO MILD“
8 Jan 2021
Word figurative mark: “dermo mild“
Year 2020 in Dpmam
4 trademark filings: Trivit …
6 Oct 2020
Managing Director: Ingo Schimmelpfennig · No longer Managing Director: Bettina Buschhoff
10 Jul 2020
Annual report for the year ending 30/06/2019 · Balance sheet for 30/06/2019 · Earnings statement for 30/06/2019 · 3 Shareholdings: Consumer Health Distribution S.A …
1 Apr 2020
Profit Transfer: Procter & Gamble Germany GmbH & Co. Operations OHG · Control: Procter & Gamble Germany GmbH & Co. Operations OHG
17 Mar 2020
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
29 Jan 2020 as Merck Selbstmedikation GmbH
Annual report for the year ending 30/11/2018 · Balance sheet for 30/11/2018 · Earnings statement for 30/11/2018 · 7 Shareholdings (7 companies)
13 Jan 2020
Managing Director: Florian S. Sieben
8 Nov 2019
Authorized signatory (ppa) (1)
28 Oct 2019
Wordmark: “I am playing“
7 Oct 2019
No longer Managing Director: Jochen Schlindwein
11 Sept 2019
Managing Director: Jens Willi Schewitz · No longer Authorized signatory (ppa): Jens Willi Schewitz
Year 2019 in Dpmam
445 trademark filings: "Kytta Fluid", "Kytta Plasma", AKTIVABION, APESIL, Alfanorm, B i o n, B.ALIV, BION, BION 3 50 Plus, BION 3 Gold, BION 3 Junior, BION 3 Senior, BION 3 active 50, BIONTA, Bion …
Year 2019 in Dpmam
1 wordmark: "Kytta Fluid", "Kytta Plasma", AKTIVABION, APESIL, Alfanorm, B i o n, B.ALIV, BION, BION 3 50 Plus, BION 3 Gold, BION 3 Junior, BION 3 Senior, BION 3 active 50, BIONTA, Bion …
2 Aug 2019
Authorized signatory (ppa) (5)
8 Jul 2019
No longer Managing Director: Erich Nobis · Managing Director (5) · Authorized signatory (ppa) (8) · No longer Authorized signatory (ppa) (2)
27 Jun 2019
Original document: “Liste der Gesellschafter“
26 Jun 2019
Original document: “Liste der Gesellschafter“
20 May 2019
Authorized signatory (ppa): Sandra Dickert
13 May 2019 as Merck Selbstmedikation GmbH
Change of headquarters: P&G Health Germany GmbH · Seat: Schwalbach am Taunus, Germany
9 May 2019
Original document: “Liste der Gesellschafter“
9 May 2019
Original document: “Gesellschaftsvertrag / Satzung / Statut“
29 Apr 2019
Managing Director: Erich Nobis, F. Schulze · ppa (4) · Change of headquarters: Merck Selbstmedikation GmbH · Address · Capital: €2,325,759 · Share­holder agreement · Proxy policy · Corporate Purpose
8 Apr 2019 as Merck Selbstmedikation GmbH
Managing Director: Frank Schulze
4 Apr 2019
Original document: “Gesellschaftsvertrag / Satzung / Statut“
20 Mar 2019 as Merck Selbstmedikation GmbH
Managing Director: Frank Schulze · No longer Managing Director: Uta Kemmerich-Keil · No longer Authorized signatory (ppa): Frank Schulze
6 Feb 2019 as Merck Selbstmedikation GmbH
Authorized signatory (ppa) (5)
12 Dec 2018 as Merck Selbstmedikation GmbH
No longer Authorized signatory (ppa) (4)
12 Dec 2018 as Merck Selbstmedikation GmbH
No longer Control: Merck Consumer Health Holding Germany GmbH, Merck Consumer Health Holding GmbH · No longer Profit Transfer: Merck Consumer Health Holding Germany GmbH, Merck Consumer Health …
12 Dec 2018 via P&G Consumer Health Germany GmbH
Company lease: Merck Consumer Health GmbH
3 Dec 2018
Original document: “Liste der Gesellschafter“
21 Nov 2018 as Merck Selbstmedikation GmbH
Capital: €2,325,759 · Share­holder agreement
21 Nov 2018
Original document: “Liste der Gesellschafter“
8 Nov 2018 as Merck Selbstmedikation GmbH
Share­holder agreement
Year 2018 in Dpmam
10 trademark filings (8 wordmarks, 1 word figurative mark): B.ALIV, CAYANOL, D-BlON, D-VION, TRIBION, VIVERA, VlON D …
25 Oct 2018
Original document: “Gesellschaftsvertrag / Satzung / Statut“
24 Oct 2018
Original document: “Gesellschaftsvertrag / Satzung / Statut“
18 Oct 2018
Original document: “Liste der Gesellschafter“
9 Oct 2018
Original document: “Liste der Gesellschafter“
17 Sept 2018 as Merck Selbstmedikation GmbH
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (3)
11 Sept 2018
Original document: “Liste der Gesellschafter“
31 Aug 2018 as Merck Selbstmedikation GmbH
Capital: €2,323,759 · Share­holder agreement
21 Aug 2018
Original document: “Gesellschaftsvertrag / Satzung / Statut“
13 Jun 2018
Original document: “Liste der Gesellschafter“
24 May 2018 as Merck Selbstmedikation GmbH
Capital: €2,025,100 · Share­holder agreement
23 May 2018 via Merck KGaA also 08/05/2018, 22/05/2017, 04/04/2017, 19/07/2016, 06/06/2016, 01/06/2015, 29/04/2015, 25/06/2014, 22/05/2014, 03/06/2013, 29/05/2013, 03/05/2012, 03/05/2012, 13/05/2011, 06/05/2011, 11/05/2010, 28/04/2010, 29/04/2009, 24/04/2009, 24/04/2008, 18/04/2008, 12/07/2007, 12/07/2007
Shareholder: MERCK KGaA
9 Apr 2018 via E. Merck KG also 11/04/2017, 03/06/2016, 23/05/2013, 25/04/2012, 10/05/2011, 27/10/2010, 04/05/2010, 28/04/2009
Shareholder: E. Merck KG
2 Mar 2018
Original document: “Gesellschaftsvertrag / Satzung / Statut“
30 Jan 2018 as Merck Selbstmedikation GmbH
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
23 Jan 2018 as Merck Selbstmedikation GmbH
No longer Managing Director: Rüdiger R. H. Demuth
Year 2018 in Euipods
12 registered designs
3 Jan 2018 as Merck Selbstmedikation GmbH
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016
Year 2017 in Dpmam
10 trademark filings (4 wordmarks, 1 figurative mark, 1 word figurative mark): CAYANOL, GEN100, Iludia, WE100, WE100 - Young for old, old for young. …
31 Aug 2017
Original document: “Liste der Gesellschafter“
31 Aug 2017
Original document: “Liste der Gesellschafter“
31 Aug 2017
Original document: “Gesellschaftsvertrag / Satzung / Statut“
12 May 2017 as Merck Selbstmedikation GmbH
Managing Director: Rüdiger R. H. Demuth · Authorized signatory (ppa): Jochen Schlindwein · No longer Authorized signatory (ppa) (1)
Year 2016 in Dpmam
32 trademark filings (18 wordmarks, 7 word figurative marks): Elumea, Elumelle, Iludia, VIGANTOLVIT, Vigantelia, Vigantiva, Vigantola, Vigantovin, WE100 - Young for old, old for young., WE100 …
30 Mar 2016
Wordmark: “MENOBION“
Year 2015 in Dpmam
2 wordmarks: APESIL, Cebion, GAVINDOL, TRIBION …
17 Sept 2015 as Merck Selbstmedikation GmbH
Managing Director: Uta Kemmerich-Keil · Authorized signatory (ppa) (2) · No longer Authorized signatory (ppa) (1)
8 Dec 2014
Original document: “Liste der Gesellschafter“
8 Dec 2014
Original document: “Gesellschaftsvertrag / Satzung / Statut“
19 Nov 2014
Wordmark: “VIGANTOLETTEN STICKS“
19 Nov 2014
Wordmark: “VIGANTOLETTEN STICKS“
30 Oct 2014
Wordmark: “APESIL“
7 May 2014 as Merck Selbstmedikation GmbH
Address
28 Nov 2013 as Merck Selbstmedikation GmbH
Profit Transfer: Merck Consumer Health Care Holding GmbH · Control: Merck Consumer Health Care Holding GmbH
Year 2013 in Dpmam
15 wordmarks: BIONTA, CEBIONELLE, DIABION, DUOBION, ISOBION, MAGNOBION, NASIMAR, NASORAL, ORGABION, OSTEOBION, OSTEOFEM, RICHELET …
19 Feb 2013 as Merck Selbstmedikation GmbH
No longer Managing Director (1) · No longer Authorized signatory (ppa) (1)
21 Nov 2012
Wordmark: “BION“
26 Jul 2012
Word figurative mark: “VITAMIN Benefit“
Year 2011 in Dpmam
4 wordmarks: FEMIBION FLOR INTIM, HEALTHPRESSO, MEDIFLOR, VIRALSAN …
7 Apr 2011 as Merck Selbstmedikation GmbH
Authorized signatory (ppa) (1)
30 Mar 2011 as Merck Selbstmedikation GmbH
Word figurative mark: “vit FOOD“
16 Nov 2010 as Merck Selbstmedikation GmbH
Managing Director: Erich Nobis · No longer Managing Director (1)
Year 2010 in Dpmam
11 trademark filings (5 wordmarks, 2 figurative marks, 3 word figurative marks): DIABION, FEMIBION EISEN VITAL, KYTTA-SEDATIVUM DRAGEES: UND DER SCHLAF KOMMT VON SELBST, MEDIFLOR, TRIBION HARMONIS …
19 Aug 2010 as Merck Selbstmedikation GmbH
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
11 Aug 2010 via Merck Consumer Health Holding GmbH also 21/08/2009, 30/06/2008, 05/11/2007
Shareholder: Merck Consumer Health Care Holding GmbH
1 Apr 2010 as Merck Selbstmedikation GmbH
No longer Authorized signatory (ppa) (1)
3 Mar 2010 as Merck Selbstmedikation GmbH
Annual report for the year ending 31/12/2008
24 Nov 2009 as Merck Selbstmedikation GmbH
No longer Authorized signatory (ppa) (1)
Year 2009 in Dpmam
6 trademark filings (2 figurative marks, 1 word figurative mark): GAVINDOL, TRITIBION …
7 Jul 2009 as Merck Selbstmedikation GmbH
No longer Managing Director (1)
5 Mar 2009 as Merck Selbstmedikation GmbH
Managing Director (1) · Address
Year 2008 in Dpmam
11 trademark filings (5 wordmarks, 5 figurative marks, 1 word figurative mark): EVION, GAVINDOL, MEDIFLOR …
2 Sept 2008 as Merck Selbstmedikation GmbH
No longer Authorized signatory (ppa) (2) · Managing Director (2) · No longer Managing Director (1)
14 Aug 2008 as Merck Selbstmedikation GmbH
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
24 Jun 2008 as Merck Selbstmedikation GmbH
Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007 · Earnings statement for 31/12/2007
13 May 2008 as Merck Selbstmedikation GmbH
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
7 Dec 2007 as Merck Selbstmedikation GmbH
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006 · Earnings statement for 31/12/2006
2 Aug 2007 via E. Merck KG
Shareholder: E. Merck OHG
1 Aug 2006 as Merck Selbstmedikation GmbH
Authorized signatory (ppa) (1)
15 Feb 2006 as Merck Selbstmedikation GmbH
Reg­is­tra­tion · ppa (6) · MD (1) · Profit Transfer: Merck Consumer Health Care Holding GmbH · Control: Merck Consumer Health Care Holding GmbH · Capital: €2,025,000 · Seat: Darmstadt, Germany …
1 Mar 2005
Wordmark: “BION“
There are no publications matching your search.

Mentions

8 Apr 2026 in Bmjfbv
No longer General partner: P&G Health Austria GmbH & Co. OG
16 Oct 2024 in Psc
Shareholding: Procter & Gamble Health Ltd
17 Sept 2019 in Ler
No longer Ultimate parent
4 Jun 2019 in Bmjfbv
General partner: P&G Health Austria GmbH & Co. OG
20 May 2019 in Hrdk also 09/05/2019
P&G Consumer Health Germany GmbH: “Liste der Gesellschafter“
2 Oct 2018 in Bmjfbv
General partner: MERCK KGaA & Co. Werk Spittal
9 Mar 2018 in Ler
No longer Ultimate parent
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.